Estée Lauder (EL) Stock Trades Down, Here Is Why
  • February 4, 2025

Estée Lauder (EL) Stock Trades Down, Here Is Why

Shares of beauty products company Estée Lauder (NYSE:EL) fell 18.2% in the morning session after the company reported underwhelming fourth-quarter results. Its EBITDA missed significantly, and its EPS guidance for next quarter fell short of Wall Street's estimates. On the other hand, Estée Lauder blew past analysts' EPS expectations this quarter. While revenue also beat analysts' estimates, sales declined year on year. The company unveiled "Beauty Reimagined," a plan to boost sales and profits b

Illumina (ILMN) Stock Trades Down, Here Is Why
  • February 4, 2025

Illumina (ILMN) Stock Trades Down, Here Is Why

Shares of genomics company Illumina (NASDAQ:ILMN) fell 6.3% in the afternoon session after China put the company on its "unreliable entity" list, opening the door to possible sanctions. The move came after the Trump administration slapped a 10% tariff on Chinese goods. Financial filings in 2024 revealed that Illumina makes about 7% of its sales from China, and it's unclear whether China's action is a short-term reaction or one with longer consequences.

Vaccine, packaged food stocks fall as Kennedy moves closer to health secretary job
  • February 4, 2025

Vaccine, packaged food stocks fall as Kennedy moves closer to health secretary job

The vote by the U.S. Senate Finance Committee paves the way for the full Senate to vote to confirm him as secretary of the U.S. Department of Health and Human Services as soon as this week. Kennedy, who has faced opposition from health groups and Democrats, has long sown doubts about the safety and efficacy of vaccines that have helped curb disease and prevent deaths for decades.

FOX (NASDAQ:FOXA) Reports Upbeat Q4
  • February 4, 2025

FOX (NASDAQ:FOXA) Reports Upbeat Q4

Cable news and media network Fox (NASDAQ:FOXA) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 19.9% year on year to $5.08 billion. Its non-GAAP profit of $0.96 per share was 50.2% above analysts’ consensus estimates.